Clinical Trial Detail

NCT ID NCT02132598
Title Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Liza Villaruz, MD
Indications

lung non-small cell carcinoma

Therapies

Cabozantinib

Age Groups: senior adult

No variant requirements are available.